A detailed history of Potomac Fund Management Inc /Adv transactions in Novo Nordisk A S stock. As of the latest transaction made, Potomac Fund Management Inc /Adv holds 14,360 shares of NVO stock, worth $1.17 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares
14,360
Holding current value
$1.17 Million
% of portfolio
1.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$85.0 - $120.04 $1.22 Million - $1.72 Million
14,360 New
14,360 $1.24 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $185B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Potomac Fund Management Inc /Adv Portfolio

Follow Potomac Fund Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Potomac Fund Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Potomac Fund Management Inc /Adv with notifications on news.